Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use

Maria Maddalena Sirufo^{1

2}, Lia Ginaldi^{1

2}, Massimo De Martinis^{1

3}

Affiliations

¹ Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
² Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL Teramo, Italy.
³ Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL Teramo, Italy. demartinis@cc.univaq.it.

Comment

Maria Maddalena Sirufo et al. World J Mens Health. 2021 Apr.

. 2021 Apr;39(2):389-390.

doi: 10.5534/wjmh.200138. Epub 2020 Nov 26.

Maria Maddalena Sirufo^{1

2}, Lia Ginaldi^{1

2}, Massimo De Martinis^{1

3}

¹ Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
² Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL Teramo, Italy.
³ Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL Teramo, Italy. demartinis@cc.univaq.it.

No abstract available

Conflict of interest statement

The authors have nothing to disclose.

Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm.
Traish AM. Traish AM. World J Mens Health. 2020 Jul;38(3):323-337. doi: 10.5534/wjmh.200012. Epub 2020 Mar 20. World J Mens Health. 2020. PMID: 32202088 Free PMC article. Review.

1. Traish AM. Health risks associated with long-term finasteride and dutasteride use: it's time to sound the alarm. World J Mens Health. 2020;38:323–337. - PMC - PubMed
1. De Martinis M, Sirufo MM, Ginaldi L. Osteoporosis: current and emerging therapies targeted to immunological checkpoints. Curr Med Chem. 2019 doi: 10.2174/0929867326666190730113123. [Epub] - DOI - PMC - PubMed
1. Lin WL, Hsieh YW, Lin CL, Sung FC, Wu CH, Kao CH. A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia. Clin Endocrinol (Oxf) 2015;82:503–508. - PubMed
1. Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, et al. Canadian Drug Safety and Effectiveness Research Network. A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride. BMC Musculoskelet Disord. 2018;19:160. - PMC - PubMed
1. De Martinis M, Sirufo MM, Polsinelli M, Placidi G, Di Silvestre D, Ginaldi L. Gender differences in osteoporosis: a single-center observational study. World J Mens Health. 2020 doi: 10.5534/wjmh.200099. [Epub] - DOI - PMC - PubMed